Literature DB >> 31504412

Maximum-fixed energy shocks for cardioverting atrial fibrillation.

Anders S Schmidt1,2,3, Kasper G Lauridsen1,2,3, Peter Torp2, Leif F Bach4, Hans Rickers2, Bo Løfgren2,3,5,6.   

Abstract

AIMS: Direct-current cardioversion is one of the most commonly performed procedures in cardiology. Low-escalating energy shocks are common practice but the optimal energy selection is unknown. We compared maximum-fixed and low-escalating energy shocks for cardioverting atrial fibrillation. METHODS AND
RESULTS: In a single-centre, single-blinded, randomized trial, we allocated elective atrial fibrillation patients to cardioversion using maximum-fixed (360-360-360 J) or low-escalating (125-150-200 J) biphasic truncated exponential shocks. The primary endpoint was sinus rhythm 1 min after cardioversion. Safety endpoints were any arrhythmia, myocardial injury, skin burns, and patient-reported pain after cardioversion. We randomized 276 patients, and baseline characteristics were well-balanced between groups (mean ± standard deviation age: 68 ± 9 years, male: 72%, atrial fibrillation duration >1 year: 30%). Sinus rhythm 1 min after cardioversion was achieved in 114 of 129 patients (88%) in the maximum-fixed energy group, and in 97 of 147 patients (66%) in the low-escalating energy group (between-group difference; 22 percentage points, 95% confidence interval 13-32, P < 0.001). Sinus rhythm after first shock occurred in 97 of 129 patients (75%) in the maximum-fixed energy group compared to 50 of 147 patients (34%) in the low-escalating energy group (between-group difference; 41 percentage points, 95% confidence interval 30-51). There was no significant difference between groups in any safety endpoint.
CONCLUSION: Maximum-fixed energy shocks were more effective compared with low-escalating energy shocks for cardioverting atrial fibrillation. We found no difference in any safety endpoint. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Atrial fibrillation; Cardioversion; Energy selection

Mesh:

Year:  2020        PMID: 31504412     DOI: 10.1093/eurheartj/ehz585

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  8 in total

Review 1.  How to Optimize Cardioversion of Atrial Fibrillation.

Authors:  K E Juhani Airaksinen
Journal:  J Clin Med       Date:  2022-06-12       Impact factor: 4.964

Review 2.  Effectiveness of alternative shock strategies for out-of-hospital cardiac arrest: A systematic review.

Authors:  Helen Pocock; Charles D Deakin; Ranjit Lall; Christopher M Smith; Gavin D Perkins
Journal:  Resusc Plus       Date:  2022-05-11

3.  Acute rate control in atrial fibrillation: an urgent need for the clinician.

Authors:  Gheorghe-Andrei Dan; Anca R Dan; Andreea Ivanescu; Adrian C Buzea
Journal:  Eur Heart J Suppl       Date:  2022-06-13       Impact factor: 1.624

4.  Investigating the efficacy of chest pressure for direct current cardioversion in atrial fibrillation: a randomised control trial protocol (Pressure-AF).

Authors:  David Ferreira; Philo Mikhail; Michael McGee; Andrew Boyle; Aaron Sverdlov; Maged William; Nicholas Jackson; Malcolm Barlow; James Leitch; Nicholas Collins; Thomas Ford; Bradley Wilsmore
Journal:  Open Heart       Date:  2021-09

Review 5.  [Adult advanced life support].

Authors:  Jasmeet Soar; Bernd W Böttiger; Pierre Carli; Keith Couper; Charles D Deakin; Therese Djärv; Carsten Lott; Theresa Olasveengen; Peter Paal; Tommaso Pellis; Gavin D Perkins; Claudio Sandroni; Jerry P Nolan
Journal:  Notf Rett Med       Date:  2021-06-08       Impact factor: 0.826

6.  Primary success of electrical cardioversion for new-onset atrial fibrillation and its association with clinical course in non-cardiac critically ill patients: sub-analysis of a multicenter observational study.

Authors:  Nozomu Shima; Kyohei Miyamoto; Seiya Kato; Takuo Yoshida; Shigehiko Uchino
Journal:  J Intensive Care       Date:  2021-07-08

7.  Cardioversion of atrial fibrillation and atrial flutter revisited: current evidence and practical guidance for a common procedure.

Authors:  Axel Brandes; Harry J G M Crijns; Michiel Rienstra; Paulus Kirchhof; Erik L Grove; Kenneth Bruun Pedersen; Isabelle C Van Gelder
Journal:  Europace       Date:  2020-08-01       Impact factor: 5.214

Review 8.  Use of Anticoagulant Therapy in Patients with Acute Myocardial Infarction and Atrial Fibrillation.

Authors:  Ratko Lasica; Lazar Djukanovic; Dejana Popovic; Lidija Savic; Igor Mrdovic; Nebojsa Radovanovic; Mina Radosavljevic Radovanovic; Marija Polovina; Radan Stojanovic; Dragan Matic; Ana Uscumlic; Milika Asanin
Journal:  Medicina (Kaunas)       Date:  2022-02-23       Impact factor: 2.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.